Literature DB >> 19139282

Amphotericin B-induced renal tubular cell injury is mediated by Na+ Influx through ion-permeable pores and subsequent activation of mitogen-activated protein kinases and elevation of intracellular Ca2+ concentration.

Takahisa Yano1, Yoshinori Itoh, Eiko Kawamura, Asuka Maeda, Nobuaki Egashira, Motohiro Nishida, Hitoshi Kurose, Ryozo Oishi.   

Abstract

Amphotericin B (AMB) is one of the most effective antifungal agents; however, its use is often limited by the occurrence of adverse events, especially nephrotoxicity. The present study was designed to determine the possible mechanisms underlying the nephrotoxic action of AMB. The exposure of a porcine proximal renal tubular cell line (LLC-PK1 cells) to AMB caused cell injury, as assessed by mitochondrial enzyme activity, the leakage of lactate dehydrogenase, and tissue ATP depletion. Propidium iodide uptake was enhanced, while terminal deoxynucleotidyl transferase-mediated dUTP nick end labeling was not affected by AMB, suggesting a lack of involvement of apoptosis in AMB-induced cell injury. The cell injury was inhibited by the depletion of membrane cholesterol with methyl-beta-cyclodextrin, which lowered the extracellular Na(+) concentration or the chelation of intracellular Ca(2+). The rise in the intracellular Ca(2+) concentration may be mediated through the activation of the ryanodine receptor (RyR) on the endoplasmic reticulum and the mitochondrial Na(+)-Ca(2+) exchanger, since cell injury was attenuated by dantrolene (an RyR antagonist) and CGP37157 (an Na(+)-Ca(2+) exchanger inhibitor). Moreover, AMB-induced cell injury was reversed by PD169316 (a p38 mitogen-activated protein [MAP] kinase inhibitor), c-Jun N-terminal kinase inhibitor II, and PD98059 (a MEK1/2 inhibitor). The phosphorylations of these MAP kinases were enhanced by AMB in a calcium-independent manner, suggesting the involvement of MAP kinases in AMB-induced cell injury. These findings suggest that Na(+) entry through membrane pores formed by the association of AMB with membrane cholesterol leads to the activation of MAP kinases and the elevation of the intracellular Ca(2+) concentration, leading to renal tubular cell injury.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19139282      PMCID: PMC2663073          DOI: 10.1128/AAC.01137-08

Source DB:  PubMed          Journal:  Antimicrob Agents Chemother        ISSN: 0066-4804            Impact factor:   5.191


  38 in total

Review 1.  Amphotericin B nephrotoxicity.

Authors:  Gilbert Deray
Journal:  J Antimicrob Chemother       Date:  2002-02       Impact factor: 5.790

2.  Clinical significance of nephrotoxicity in patients treated with amphotericin B for suspected or proven aspergillosis.

Authors:  J R Wingard; P Kubilis; L Lee; G Yee; M White; L Walshe; R Bowden; E Anaissie; J Hiemenz; J Lister
Journal:  Clin Infect Dis       Date:  1999-12       Impact factor: 9.079

3.  Apoptosis contributes to amphotericin B-induced nephrotoxicity.

Authors:  D E Varlam; M M Siddiq; L A Parton; H Rüssmann
Journal:  Antimicrob Agents Chemother       Date:  2001-03       Impact factor: 5.191

Review 4.  Mitochondria and calcium: from cell signalling to cell death.

Authors:  M R Duchen
Journal:  J Physiol       Date:  2000-11-15       Impact factor: 5.182

5.  Role of poly(ADP-ribose)polymerase in cisplatin-induced injury in LLC-PK1 cells.

Authors:  Yuki Shino; Yoshinori Itoh; Toshio Kubota; Takahisa Yano; Toshiaki Sendo; Ryozo Oishi
Journal:  Free Radic Biol Med       Date:  2003-10-15       Impact factor: 7.376

6.  Reduced nephrotoxicity of conventional amphotericin B therapy after minimal nephroprotective measures: animal experiments and clinical study.

Authors:  J Mayer; M Doubek; J Doubek; D Horký; P Scheer; M Stepánek
Journal:  J Infect Dis       Date:  2002-07-11       Impact factor: 5.226

7.  17beta-estradiol rapidly mobilizes intracellular calcium from ryanodine-receptor-gated stores via a PKC-PKA-Erk-dependent pathway in the human eccrine sweat gland cell line NCL-SG3.

Authors:  Ruth W Muchekehu; Brian J Harvey
Journal:  Cell Calcium       Date:  2008-01-22       Impact factor: 6.817

8.  Cyclic AMP reverses radiocontrast media-induced apoptosis in LLC-PK1 cells by activating A kinase/PI3 kinase.

Authors:  Takahisa Yano; Yoshinori Itoh; Toshiaki Sendo; Toshio Kubota; Ryozo Oishi
Journal:  Kidney Int       Date:  2003-12       Impact factor: 10.612

Review 9.  Endoplasmic reticulum Ca(2+) homeostasis and neuronal death.

Authors:  A Verkhratsky; E C Toescu
Journal:  J Cell Mol Med       Date:  2003 Oct-Dec       Impact factor: 5.310

10.  Effect of heat-treated amphotericin B on renal and fungal cytotoxicity.

Authors:  Karen Bartlett; Edwin Yau; Scott C Hartsel; Alison Hamer; Gina Tsai; Dan Bizzotto; Kishor M Wasan
Journal:  Antimicrob Agents Chemother       Date:  2004-01       Impact factor: 5.191

View more
  14 in total

1.  Long open amphotericin channels revealed in cholesterol-containing phospholipid membranes are blocked by thiazole derivative.

Authors:  Oleg Ya Shatursky; Olexander V Romanenko; Nina H Himmelreich
Journal:  J Membr Biol       Date:  2014-01-09       Impact factor: 1.843

Review 2.  Ischemic kidney injury and mechanisms of tissue repair.

Authors:  Marwa El Sabbahy; Vishal S Vaidya
Journal:  Wiley Interdiscip Rev Syst Biol Med       Date:  2010-12-31

Review 3.  Pathophysiology of acute kidney injury.

Authors:  David P Basile; Melissa D Anderson; Timothy A Sutton
Journal:  Compr Physiol       Date:  2012-04       Impact factor: 9.090

Review 4.  Amphotericin B membrane action: role for two types of ion channels in eliciting cell survival and lethal effects.

Authors:  B Eleazar Cohen
Journal:  J Membr Biol       Date:  2010-11-18       Impact factor: 1.843

5.  Amphotericin B potentiates the anticancer activity of doxorubicin on the MCF-7 breast cancer cells.

Authors:  Farzaneh Tavangar; Hamid Sepehri; Marie Saghaeian Jazi; Jahanbakhsh Asadi
Journal:  J Chem Biol       Date:  2017-06-05

6.  A phospholipid-apolipoprotein A-I nanoparticle containing amphotericin B as a drug delivery platform with cell membrane protective properties.

Authors:  Braydon L Burgess; Giorgio Cavigiolio; Michelle V Fannucchi; Beate Illek; Trudy M Forte; Michael N Oda
Journal:  Int J Pharm       Date:  2010-08-07       Impact factor: 5.875

7.  Incidence, Predictors, and Impact on Hospital Mortality of Amphotericin B Nephrotoxicity Defined Using Newer Acute Kidney Injury Diagnostic Criteria.

Authors:  Paulo Novis Rocha; Carla Dinamérica Kobayashi; Luna de Carvalho Almeida; Camilla de Oliveira Dos Reis; Barbara Mendes Santos; Marshall Jay Glesby
Journal:  Antimicrob Agents Chemother       Date:  2015-05-26       Impact factor: 5.191

8.  Could dantrolene be explored as a repurposed drug to treat COVID-19 patients by restoring intracellular calcium homeostasis?

Authors:  B Jiang; S Liang; G Liang; H Wei
Journal:  Eur Rev Med Pharmacol Sci       Date:  2020-10       Impact factor: 3.507

9.  Brief Report: Effects of Tenofovir and Amphotericin B Deoxycholate Coadministration on Kidney Function in Patients Treated for Cryptococcal Meningitis.

Authors:  Reuben Kiggundu; Bozena M Morawski; Nathan C Bahr; Joshua Rhein; Abdu K Musubire; Darlisha A Williams; Mahsa Abassi; Henry W Nabeta; Kathy H Hullsiek; David B Meya; David R Boulware
Journal:  J Acquir Immune Defic Syndr       Date:  2016-01-01       Impact factor: 3.731

Review 10.  Lipid Systems for the Delivery of Amphotericin B in Antifungal Therapy.

Authors:  Célia Faustino; Lídia Pinheiro
Journal:  Pharmaceutics       Date:  2020-01-01       Impact factor: 6.321

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.